Valsartan in the treatment of heart attack survivors
Bodh I JugduttDivision of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaAbstract: Survivors of myocardial infarction (MI) are at high risk of disability and death. This is due to infarct-related complications such as heart failure, cardiac remodeling with progre...
Main Author: | Bodh I Jugdutt |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2006-06-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/valsartan-in-the-treatment-of-heart-attack-survivors-peer-reviewed-article-VHRM |
Similar Items
-
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly
by: Bodh I Jugdutt
Published: (2010-12-01) -
Modification of left ventricular geometry and function during healing after acute myocardial infarction
by: Jugdutt, Bodh I.
Published: (2006) -
Experimental Heart Failure Models and Their Pathophysiological Characterization
by: Peter Moritz Becher, et al.
Published: (2016-01-01) -
Enhanced regional AT2-receptor and PKCε expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction
by: Bodh I Jugdutt, et al.
Published: (2001-06-01) -
Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy
by: Sergio Iannazzo, et al.
Published: (2008-09-01)